List view / Grid view

Ebola virus

Johnson & Johnson to donate 200,000 vaccine regimens to curb Ebola outbreak

14 May 2021 | By Hannah Balfour (European Pharmaceutical Review)

To prevent the spread of the Ebola virus in West Africa, Johnson & Johnson is donating vaccines for a WHO early access clinical programme.

article

EMA’s transformative treatments of 2020

24 February 2021 | By Hannah Balfour (European Pharmaceutical Review)

In this article, we summarise the trial findings for the European Medicines Agency’s 13 most transformative therapies of 2020.

news

BCG vaccine protects newborns against a variety of infectious diseases, finds study

18 February 2021 | By Hannah Balfour (European Pharmaceutical Review)

According to researchers, ensuring that newborns in areas with high rates of infectious disease receive the BCG vaccine at birth, could have a major impact on infections and deaths.

news

Gavi to make 500,000 doses of Ebola vaccine available for outbreak response

22 January 2021 | By Hannah Balfour (European Pharmaceutical Review)

The global stockpile will provide developing countries responding to Ebola outbreaks with doses of the approved single-dose Ebola vaccine, rVSV∆G-ZEBOV-GP, live, free of charge.

Red Ebolavirus particle on a black background

news

FDA approves Ebanga (Ansuvimab-zykl) for the treatment of Ebola

5 January 2021 | By Hannah Balfour (European Pharmaceutical Review)

Ebanga was approved based on its ability to reduce 28-day mortality in patients with confirmed Ebolavirus infection.

Orange worm-like shape indicating an ebola virus particle surrounded by red discs indicating redblood cells

news

US FDA approves the first Ebola virus treatment – Inmazeb

15 October 2020 | By Hannah Balfour (European Pharmaceutical Review)

The US Food and Drug Administration (FDA) has approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) for the treatment of Zaire ebolavirus infection in adults and children.

article

Developing a preventive vaccine regimen to tackle Ebola

25 August 2020 | By Nikki Withers (European Pharmaceutical Review)

Earlier this year, Johnson & Johnson announced the first major regulatory approval of a vaccine developed by Janssen for the prevention of Ebola. Nikki Withers spoke with the Global Head of Vaccines, Johan Van Hoof, to discover what technologies were used and how they are now being leveraged to develop…

gloved hand holding a syringe labelled 'Ebola vaccination'

news

EMA gives positive opinion to investigational Ebola vaccine regimen

8 June 2020 | By Hannah Balfour (European Pharmaceutical Review)

Developed by Janssen, the two-dose regimen has already been given to 60,000 patients and now has the positive opinion of the Committee for Medicinal Products for Human Use (CHMP).

bags of blood plasma hanging for infusion

news

COVID-19 convalescent plasma therapy shown to be safe and effective

3 June 2020 | By Hannah Balfour (European Pharmaceutical Review)

Scientists reveal 76 percent of critically ill trial participants treated with convalescent plasma are recovering, with almost half now discharged from hospital.

news

Radiance could be the key to faster viral detection

19 September 2018 | By Iqra Farooq (European Pharmaceutical Review)

Viruses explored through Radiance, an instrument designed to improve the process of analysis, ensures quick and efficient viral detection...

news

NIH begins testing Ebola treatment in early-stage trial

28 May 2018 | By European Pharmaceutical Review

Scientists developed monoclonal antibody from Ebola survivor...

news

New uses for existing antiviral drugs

27 April 2018 | By European Pharmaceutical Review

A test of 55 antiviral drugs that are known to be safe in humans found 7 compounds that show new effects against multiple viruses...

news

High doses of favipiravir may be effective against Ebola

28 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)

High doses of favipiravir extended survival in non-human primates infected with Ebola virus, according to a new study....

news

Experimental Ebola vaccines elicit year-long immune response

13 October 2017 | By Dr Zara Kassam (European Pharmaceutical Review)

Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year...

news

Lessons from Ebola: How to improve disease outbreak management

16 May 2017 | By Niamh Marriott, Junior Editor

A new approach to information gathering could allow scientists to quickly identify the most effective way to manage a disease outbreak...

Cookie	Description
cookielawinfo-checkbox-advertising-targeting	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Cookie	Description
cf_ob_info	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	This cookie is set by Youtube and is used to track the views of embedded videos.

Cookie	Description
bcookie	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	This cookie is set by LinkedIn and used for routing.
lissc	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Cookie	Description
advanced_ads_browser_width	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Recommended

Ebola virus